Maternal anticonvulsants and perinatal risk

Area of Science:

• Obstetrics and Gynecology
• Neonatal Medicine
• Pharmacology

Background:

• Anticonvulsant therapy in epileptic mothers is linked to a 2-3 fold increase in perinatal mortality.
• Congenital malformations alone do not explain the elevated mortality rates.
• A specific case highlights a recurrent severe bleeding disorder in successive offspring.

Purpose of the Study:

• To investigate the causes of increased neonatal mortality in infants exposed to anticonvulsants.
• To identify preventable factors contributing to neonatal death and morbidity.
• To discuss the role of vitamin K in neonatal bleeding disorders.

Main Methods:

• Literature review of perinatal mortality in infants of epileptic mothers on anticonvulsants.
• Case report detailing a family with recurrent neonatal bleeding disorders.
• Discussion of neonatal physiology, vitamin K metabolism, and potential preventative strategies.

Main Results:

• Anticonvulsant drug exposure is associated with significantly increased perinatal mortality.
• A severe, heritable bleeding disorder was observed in successive neonates.
• Vitamin K deficiency is proposed as a critical, preventable cause of neonatal morbidity and mortality.

Conclusions:

• Neonatal bleeding disorders, responsive to vitamin K, represent a significant and preventable cause of death and illness.
• Comprehensive prenatal care, including vitamin K supplementation, is crucial for infants of mothers on anticonvulsant therapy.
• Further research into the specific mechanisms and optimal preventative strategies is warranted.